Shephard Mpofu - May 23, 2024 Form 4 Insider Report for ACELYRIN, Inc. (SLRN)

Role
Chief Medical Officer
Signature
/s/ Sanam Pangali, Attorney-in-fact
Stock symbol
SLRN
Transactions as of
May 23, 2024
Transactions value $
$0
Form type
4
Date filed
5/24/2024, 07:10 PM
Previous filing
May 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLRN Employee Stock Option (right to buy) Award $0 +329K $0.00 329K May 23, 2024 Common Stock 329K $4.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option vest on May 9, 2025, and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service.